Work

S449 Lirentelimab (AK002) Safety and Efficacy in Patients With Higher Eosinophil Thresholds: Supplementary Analysis of Phase 2/3 EoE KRYPTOS Trial

Year: 2022

Type: conference-abstract

Source: The American Journal of Gastroenterology

DOI: 10.14309/01.ajg.0000858436.90680.1a

Authors: Evan Dellon, Mirna Chehade, Robert M. Genta, David A. Leiman, Kathryn A. Peterson, Jonathan Spergel, Joshua Wechsler, Enoch Bortey, Alan T. Chang, Ikuo Hirano

Institutions: University of North Carolina at Chapel Hill, Icahn School of Medicine at Mount Sinai, Baylor College of Medicine, Duke University, Duke Medical Center, University of Utah, University of Pennsylvania, Lurie Children's Hospital, Allakos (United States), Northwestern University

Language: English

Topic: Eosinophilic Esophagitis

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4316076891

Cites:

Cited by: 4

Related to: 10